by Chloe Sullivan | Jan 20, 2026 | UPC
To briefly recap the key events leading up to this decision, the US Supreme Court found a lack of enablement when assessing the PCSK9 antibody claims in Amgen’s US patent and the Munich Central Division of the UPC initially revoked the European equivalent based on...
by Luke Pettit | Jan 15, 2026 | UPC
Background The UPC Court of Appeal’s decision in Otec v. Steros provides an interesting insight into claim interpretation and the constraints on relying on post-filing experimental evidence at the UPC. The case, UPC Court of Appeal decision 579/2025, arose from a...
by David Eyre | Dec 22, 2025 | EPO
Background Under G 1/92, a product on the market was not considered “available” as prior art under Article 54(2) EPC if the skilled person could not reproduce it without undue burden. This created a peculiar legal fiction: a product could be purchased yet legally...
by Sean Hutchinson | Dec 19, 2025 | Trademarks
Background For a democracy to function, it is essential that every politician standing for office can voice their opinion and that every political party hoping to form the next government can promote their agenda. This cornerstone of democratic society, encompassed by...
by Agne Augustinaite | Dec 10, 2025 | UK
One recent example involves Nvidia’s attempt to secure a patent for methods of playing a video game that uses AI technology. In assessing this case, the UKIPO considered key issues surrounding patentability, offering valuable insight into how such inventions are...
by Alyson Lam | Dec 2, 2025 | EPO
In a further development, T1849/23 has become the first case where clear claim language is broadened by definitions and/or embodiments provided in the description. Background T 1849/23 concerned an appeal filed by Alois Kober GmbH, the Opponent, against the Opposition...
Recent Comments